Partial Compliance with Antipsychotics Increases Mental Health Hospitalizations in Schizophrenic Patients: Analysis of a National Managed Care Database

Por Kozma, Chris M., Weiden, Peter J.
Publicado em 2009

Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension

Por Kozma, Chris M, Dirani, Riad G, Canuso, Carla M, Mao, Lian
Publicado em 2010

Trends in Neutropenia-Related Inpatient Events

Por Kozma, Chris M., Dickson, Michael, Chia, Victoria, Legg, Jason, Barron, Richard
Publicado em 2012

Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis

Por Kozma, Chris M, Dickson, Michael, Phillips, Amy L, Meletiche, Dennis M
Publicado em 2013

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study

Por Kozma, Chris M, Paris, Andrew L, Plauschinat, Craig A, Slaton, Terra, Mackowiak, John I
Publicado em 2011

Association between Sitagliptin Adherence and Self-Monitoring of Blood Glucose

Por Nigam, Somesh, Virdi, Naunihal S, Daskiran, Mehmet, Kozma, Chris M, Paris, Andrew, Dickson, William M
Publicado em 2012

Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluati...

Por Crivera, Concetta, DeSouza, Cherilyn, Kozma, Chris M, Dirani, Riad D, Mao, Lian, Macfadden, Wayne
Publicado em 2011

Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR

Por Paris, Andrew, Kozma, Chris M., Chow, Wing, Patel, Anisha M., Mody, Samir H., Kim, Myoung S.
Publicado em 2013

A retrospective analysis to identify predictors of COPD-related rehospitalization

Por Roberts, Melissa H., Clerisme-Beaty, Emmanuelle, Kozma, Chris M., Paris, Andrew, Slaton, Terra, Mapel, Douglas W.
Publicado no BMC Pulm Med (2016)

Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results

Por Dirani Riad D, Kozma Chris M, Crivera Concetta, DeSouza Cherilyn, Macfadden Wayne, Mao Lian, Rodriguez Stephen C
Publicado em 2011-10-01

Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results

Por Macfadden, Wayne, DeSouza, Cherilyn, Crivera, Concetta, Kozma, Chris M, Dirani, Riad D, Mao, Lian, Rodriguez, Stephen C
Publicado em 2011

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium

Por Macfadden Wayne, Jacobs An, Crivera Concetta, Otten Patrick, Kozma Chris M, DeSouza Cherilyn, Peuskens Joseph, Olivares José M, Lambert Tim, Mao Lian, Rodriguez Stephen C, Dirani Riad, Akhras Kasem S
Publicado em 2011-04-01

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium

Por Lambert, Tim, Olivares, José M, Peuskens, Joseph, DeSouza, Cherilyn, Kozma, Chris M, Otten, Patrick, Crivera, Concetta, Jacobs, An, Macfadden, Wayne, Mao, Lian, Rodriguez, Stephen C, Dirani, Riad, Akhras, Kasem S
Publicado em 2011